Market Cap ₹39 Cr.
Stock P/E
P/B 3.1
Current Price ₹31
Book Value ₹ 10
Face Value 10
52W High ₹51.5
Dividend Yield 0%
52W Low ₹ 28.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|
| Net Sales | 122 | 96 | 203 | 150 | |
| Other Income | 0 | 0 | 0 | 0 | |
| Total Income | 122 | 96 | 203 | 150 | |
| Total Expenditure | 121 | 95 | 200 | 148 | |
| Operating Profit | 1 | 2 | 3 | 3 | |
| Interest | 1 | 0 | 0 | 1 | |
| Depreciation | 0 | 0 | 0 | 0 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 0 | 1 | 2 | 2 | |
| Provision for Tax | 0 | 0 | 1 | 1 | |
| Profit After Tax | 0 | 1 | 2 | 2 | |
| Adjustments | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 0 | 1 | 2 | 2 | |
| Adjusted Earnings Per Share | 0.3 | 0.9 | 2.2 | 1.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -26% | 7% | 0% | 0% |
| Operating Profit CAGR | 0% | 44% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 10% | 10% | 8% | 8% |
| ROCE Average | 14% | 14% | 12% | 12% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Shareholder's Funds | 12 | 13 | 15 | 16 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -0 | -0 | -0 | -0 |
| Total Current Liabilities | 13 | 9 | 8 | 10 |
| Total Liabilities | 25 | 22 | 23 | 26 |
| Fixed Assets | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2 | 1 | 1 | 1 |
| Total Current Assets | 23 | 20 | 22 | 25 |
| Total Assets | 25 | 22 | 23 | 26 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 0 | 2 | 1 |
| Cash Flow from Operating Activities | 0 | 2 | -1 | -1 |
| Cash Flow from Investing Activities | 1 | 0 | -0 | -0 |
| Cash Flow from Financing Activities | -1 | -1 | -0 | 2 |
| Net Cash Inflow / Outflow | -1 | 1 | -1 | 2 |
| Closing Cash & Cash Equivalent | 0 | 2 | 1 | 2 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.28 | 0.94 | 2.18 | 1.79 |
| CEPS(Rs) | 0.39 | 0.98 | 2.21 | 1.85 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 13.79 | 14.73 | 17.02 | 18.81 |
| Core EBITDA Margin(%) | 0.57 | 1.32 | 1.41 | 1.72 |
| EBIT Margin(%) | 0.69 | 1.61 | 1.43 | 1.75 |
| Pre Tax Margin(%) | 0.25 | 1.14 | 1.23 | 1.38 |
| PAT Margin (%) | 0.16 | 0.83 | 0.91 | 1.02 |
| Cash Profit Margin (%) | 0.27 | 0.87 | 0.93 | 1.05 |
| ROA(%) | 0.81 | 3.42 | 8.3 | 6.25 |
| ROE(%) | 1.69 | 6.52 | 13.71 | 10 |
| ROCE(%) | 5.87 | 10.47 | 18.04 | 13.56 |
| Receivable days | 53.85 | 65.28 | 29.51 | 34.04 |
| Inventory Days | 0 | 0 | 0 | 0 |
| Payable days | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.02 | 0.01 | 0.01 | 0.08 |
| EV/Core EBITDA(x) | 2.34 | 0.58 | 0.76 | 4.38 |
| Net Sales Growth(%) | 0 | -21.58 | 112.08 | -26.05 |
| EBIT Growth(%) | 0 | 81.48 | 88.39 | -9.17 |
| PAT Growth(%) | 0 | 299.55 | 134.15 | -17.62 |
| EPS Growth(%) | 0 | 231.45 | 133.44 | -17.94 |
| Debt/Equity(x) | 0.23 | 0.19 | 0.18 | 0.35 |
| Current Ratio(x) | 1.81 | 2.27 | 2.63 | 2.5 |
| Quick Ratio(x) | 1.81 | 2.27 | 2.63 | 2.5 |
| Interest Cover(x) | 1.56 | 3.48 | 7.24 | 4.76 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Mar 2024 |
|---|---|
| Promoter | 67 |
| FII | 0 |
| DII | 0 |
| Public | 33 |
| Others | 0 |
| Total | 100 |
| # | Mar 2024 |
|---|---|
| Promoter | 0.85 |
| FII | 0 |
| DII | 0 |
| Public | 0.42 |
| Others | 0 |
| Total | 1.27 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
